NCT06540885View on ClinicalTrials.gov

A Comparison Between Palonosetron Versus Granisetron as PONV Prophylaxis in Scoliotic Patients Undergoing Spine Surgery

PHASE4RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 6, 2025

Primary Completion Date

July 31, 2026

Study Completion Date

September 30, 2026

Conditions

Postoperative Nausea and VomitingScoliosis

Interventions

DRUG

Palonosetron (Group P)

Group P will be receiving palonosetron 1.5mcg/kg before the commencement of general anaesthesia

DRUG

Granisetron (Group G)

Group G participants will receive IV Granisetron 1mg at the start of wound closure

Trial Locations (2)

50603

RECRUITING

University Malaya Medical Centre, Kuala Lumpur

59100

RECRUITING

University Malaya, Pantai Valley

All Listed Sponsors

lead

University of Malaya

OTHER

NCT06540885 - A Comparison Between Palonosetron Versus Granisetron as PONV Prophylaxis in Scoliotic Patients Undergoing Spine Surgery | Biotech Hunter | Biotech Hunter